These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 36333736)

  • 1. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Liver Disease in Patients with Prediabetes and Overweight or Obesity.
    Arias-Fernández M; Fresneda S; Abbate M; Torres-Carballo M; Huguet-Torres A; Sánchez-Rodríguez C; Bennasar-Veny M; Yañez AM; Busquets-Cortés C
    Metabolites; 2023 Apr; 13(4):. PubMed ID: 37110189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
    Lee CH; Han KD; Kim DH; Kwak MS
    Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes.
    Busquets-Cortés C; Bennasar-Veny M; López-González AA; Fresneda S; Aguiló A; Yanez A
    BMJ Open; 2021 Aug; 11(8):e045498. PubMed ID: 34433590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y; Liu J; Wang G; Wang Y
    Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
    Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
    Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
    Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.
    Silaghi CA; Silaghi H; Colosi HA; Craciun AE; Farcas A; Cosma DT; Hancu N; Pais R; Georgescu CE
    Clujul Med; 2016; 89(1):82-8. PubMed ID: 27004029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
    Giorda C; Forlani G; Manti R; Mazzella N; De Cosmo S; Rossi MC; Nicolucci A; Russo G; Di Bartolo P; Ceriello A; Guida P;
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings.
    de Silva MHAD; Hewawasam RP; Kulatunge CR; Chamika RMA
    BMC Pediatr; 2022 Aug; 22(1):511. PubMed ID: 36042456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults.
    Kanerva N; Sandboge S; Kaartinen NE; Männistö S; Eriksson JG
    Am J Clin Nutr; 2014 Oct; 100(4):1133-8. PubMed ID: 25099548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between dietary sodium intake and non-alcoholic fatty liver disease in the US population.
    Zhou L; Yang Y; Feng Y; Zhao X; Fan Y; Rong J; Zhao L; Yu Y
    Public Health Nutr; 2021 Apr; 24(5):993-1000. PubMed ID: 32312347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
    Huang X; Xu M; Chen Y; Peng K; Huang Y; Wang P; Ding L; Lin L; Xu Y; Chen Y; Lu J; Wang W; Bi Y; Ning G
    Medicine (Baltimore); 2015 Oct; 94(40):e1682. PubMed ID: 26448014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
    PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
    Arafa A; Kashima R; Matsumoto C; Kokubo Y
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.